AzTrials
AzTrials

Anesthesia for Cesarean DeliveryNCT05727449

General or Spinal Anesthesia for Cesarean Delivery

An observational study of Anesthesia for Cesarean Delivery, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During the cesarean deliveries, one of the anesthesia techniques, regional anesthesia or general anesthesia (GA) is prefered. Spinal anesthesia (SA) is preferred among the regional anesthesia methods because the onset of anesthesia is faster and muscle relaxation is more suitable for cesarean section anesthesia. Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Anesthesia for Cesarean Delivery
What is being tested?
General Anesthesia and Spinal Anesthesia
Type of treatment
Surgery or procedure
How many people
862 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2019to 1 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: The pregnant women and their babies in 01.01.2019 - 31.12.2019.

Who may be able to join

  • The pregnant women who delivered with cesarean section

Who cannot join

  • The pregnant women who delivered with spontan vaginal delivery.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Medeniyet University

    Istanbul, 34730

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of The Effects of General and Spinal Anesthesia for Cesarean Delivery on Maternal and Fetal Outcomes: A Retrospective Analysis of Data in a Third Level Hospital

During the cesarean deliveries, one of the anesthesia techniques, regional anesthesia or general anesthesia (GA) is prefered. Spinal anesthesia (SA) is preferred among the regional anesthesia methods because the onset of anesthesia is faster and muscle relaxation is more suitable for cesarean section anesthesia. Although both methods have advantages and disadvantages, the anesthesia method to be chosen may vary depending on the condition of the mother and fetus.

The goal of this retrospective clinical trial is to compare general and spinal anesthesia in cesarean deliveries. The main questions it aims to answer are:

  • Are the anesthesia techniques effect maternal outcome?
  • Are the anesthesia techniques effect fetal outcome?
Being tested
General Anesthesia, Spinal Anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • General AnesthesiaProcedure or surgery

    General Anesthesia was intruduced for Cesarean Delivery

  • Spinal AnesthesiaProcedure or surgery

    Spinal Anesthesia was intraduced for Cesarean Delivery

Study groups in NCT05727449
Study groupRoleWhat they receive
General Anesthesia for Cesarean DeliveryNot described
Receives: Procedure: General Anesthesia
Spinal Anesthesia for Cesarean DeliveryNot described
Receives: Procedure: Spinal Anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Apgar 1st minute score

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health

    Measured: 1st minute after birth

  2. Apgar 5th minute score

    The Apgar score is based on a total score of 1 to 10. The higher the score, the better the baby is doing after birth. A score of 7, 8, or 9 is normal and is a sign that the newborn is in good health

    Measured: 5th minute after birth

  3. Umbilical Cord Blood pH

    pH values from umblical cord blood sampling

    Measured: at the time of birth

  4. Umbilical Cord Blood PCO2

    mmHg

    Measured: at the time of birth

  5. Umbilical Cord Blood HCO3

    mEq/L

    Measured: at the time of birth

  6. Umbilical Cord Blood Lactate

    mmol/L

    Measured: at the time of birth

  7. Umbilical Cord Blood Base Excess

    mEq/L

    Measured: at the time of birth

  8. need for neonatal intensive care

    need for neonatal intensive care

    Measured: up to 24 hours

  9. need for maternal intensive care

    need for maternal intensive care

    Measured: up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2023
  2. Study start1 Jan 2019
  3. Primary completion31 Dec 2019
  4. Study completion1 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
862 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05727449
Sponsor's protocol ID
IstanbulMU Cesarean Delivery
Status last verified
Feb 2023
First submitted
22 Jan 2023
Last updated
22 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia for Cesarean Delivery, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Apgar 1st minute score (time frame: 1st minute after birth). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in